Dr. Peter Marks, the FDA’s top vaccine official and a key figure in the first Trump administration’s Operation Warp Speed, was ousted from his post earlier this month.
Dr. Peter Marks is an American hematologist-oncologist who has served as the director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) since 2016.
As CBER director, Marks was responsible for reviewing and providing advice during product development, evaluating applications, and making approval decisions based on safety and effectiveness data.
He oversaw the FDA’s vaccine programs and played a pivotal part in the rapid development and approval of the experimental COVID-19 vaccines under Operation Warp Speed during President Donald Trump’s first term.
Sources close to the matter told the Wall Street Journal that Marks submitted his resignation on Friday after a blunt ultimatum from a Health and Human Services (HHS) official: step down voluntarily or face termination.
His exit, effective April 5, marks yet another victory for HHS Secretary Robert F. Kennedy Jr.’s aggressive push to purge the federal health apparatus of what he calls entrenched bureaucrats peddling “misinformation and lies.”
It was very telling that Big Pharma stocks plunged following his resignation.
Shares of vaccine makers Moderna and Novavax, along with several other biotech companies, plunged following his resignation.
Now, Marks is out hitting the Sunday shows and attacking Robert Kennedy Jr. It makes you wonder who is behind this?
The Disgraced former FDA official is ALREADY defending Big Pharma from RFK Jr’s groundbreaking study on autism.
This is how committed the Big Money players are with keeping the vaccines flowing no matter how many Americans will be injured or killed.
Expect to see a lot more of Peter Marks in the coming weeks out on the fake news trashing Robert Kennedy, Jr. How pathetic.
The post Fired FDA Chief Is Now Out Trashing RFK Jr. and his Autism Study on the Fake News – Big Pharma Has Most to Lose appeared first on The Gateway Pundit.